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Hartmut GrasemannAbstract
Childhood obesity and incidence of asthma are increasing globally. The parallel increase of the two suggests that
obesity and asthma may be related and that abnormalities in the lipid and/or glucose metabolism may contribute
to the pathogenesis of asthma. The clinical presentation of obese asthma is distinct from other asthma phenotypes
and depending on age of onset of symptoms. Asthma in obese people tends to be more severe, not typically
associated with allergy, and less responsive to standard anti-inflammatory therapy, including corticosteroids. Obesity
and obesity-related comorbidities may lead to asthma via a number of mechanisms including changes in lung
mechanics, the nitric oxide metabolism, and by causing inflammation. Furthermore, evidence suggests that nutrition
during pregnancy contributes to intrauterine immune and metabolic programming in the offspring, which may
have major influences on predisposition to cardiovascular, metabolic, and allergic diseases, including asthma, later
in life. This review will highlight some suggested mechanistic links between obesity and diabetes with asthma.
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This review will summarize reported evidence of a pos-
sible link between obesity, diabetes mellitus, and asthma
highlighting the potential roles of inflammation and ab-
normalities in the L-arginine/nitric oxide metabolism as
well as metabolic and immune programming. An associ-
ation between a greater body mass index (BMI) and in-
creased risk of asthma in both children and adults has
been repeatedly shown in prospective, population-based
studies [1-5]. Nearly 30% of children are overweight or
obese in the United States [6], where childhood obesity
rates have tripled in the past three decades [7,8]. It is
well known that obesity is associated with the develop-
ment of insulin resistance and type II diabetes [9], but
the increase in obesity also parallels an increase in the
incidence of allergic disease in early life, particularly
food allergy [10,11], as well as asthma [12,13].
The simultaneous increment in the prevalence of these
conditions among children could be incidental but may
also suggest common underlying predisposing or con-
tributing factors and/or a causal relationship of meta-
bolic conditions with allergic disease and specifically
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Three study demonstrated significant associations be-
tween overweight/obesity with asthma and eczema, but
not rhinoconjunctivitis [19]. Interestingly, in some stud-
ies, the association between obesity and asthma was
found to be stronger in non-atopic than atopic children
[20,21], and the association between BMI and asthma
seems to be stronger among girls than boys [1,22-24].
Clinically important, obese asthmatics tend to present
with more and severe symptoms and have poorly con-
trolled asthma although they use more medications, and
recovery from acute exacerbations is slower compared
to their lean counterparts [25-28]. While it is conceiv-
able that intensified treatments with high-dose inhaled
or systemic corticosteroids as well as reduced physical
activity in obese asthmatics contribute to weight gain, it
is also important to notice that asthma-related outcomes
in obese asthmatics can be improved with weight loss
[29-31]. This not only provides further evidence for a
causal role of obesity for asthma but also implies that
weight loss should be attempted as supportive interven-
tion in the treatment of obese/overweight asthmatics.Review
Phenotypic distinction
A number of studies identified obesity in children and
adolescents as a risk factor for asthma, more severen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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asthma-related hospitalizations [17,25,26,32-34]. The age
of the weight gain may play a role, as pronounced weight
gain early in life was identified as a risk factor for develop-
ing asthma in the first 6 years of age [35]. Two types of
asthma in obese subjects can be distinguished by age of
onset and clinical presentation. Early-onset asthma in
obese presents before the age of 12 years, has no gender
preference, and is characterized by severely decreased pul-
monary function, significant airway hyperresponsiveness,
and poor asthma control. These patients are atopic; serum
immunoglobulin E (IgE) is increased, airway inflammation
is eosinophilic, and fraction of exhaled nitric oxide (FeNO)
is high [28]. In contrast, obese late-onset asthmatics be-
come symptomatic after the age of 12 and are predomin-
antly females without atopic characteristics. Compared to
early-onset asthmatics, they have little airway obstruction
with less airway hyperresponsiveness and better asthma
control. This phenotype has a TH2 low profile with pre-
dominant neutrophilic airway infiltration [36], which may
at least in part explain the poor response to standard
asthma therapy in this patient group.
Effect of obesity on pulmonary function and airway
responsiveness
Respiratory symptoms including shortness of breath with
exercise in obese asthma may be mistaken for being rela-
ted to the obesity alone; thus, pulmonary function testing
should be performed to rule out a diagnosis of asthma.
However, increased body fat deploys direct mechanical
effects on the respiratory system independent of asthma.
Obese individuals breathe at low tidal volumes and high re-
spiratory rate. Increased BMI leads to a reduced functional
residual capacity and expiratory reserve volume [15,16].
Pulmonary function tests in patients with BMI >30 may in
addition reveal decreased total lung capacity, vital lung
capacity, and residual volume [37]. Diabetes and insulin re-
sistance have also been reported to be linked to lung func-
tion, and insulin resistance is associated with reduced lung
function independent of diabetes, even after controlling for
BMI [38-41].
Interestingly, impaired respiratory mechanics in obese
people may also contribute to the development of asthma.
Breathing at lower lung volumes results in airway narrow-
ing and thereby increased resistance, which may contrib-
ute to airway hyperresponsiveness (AHR), a characteristic
feature of asthma [42-45]. Whether obesity enhances or
modifies AHR in children with asthma however remains
unclear, as studies have revealed inconsistent results. No
effect of BMI on AHR was found in participants of the
Childhood Asthma Management Program (CAMP) after
adjusting for baseline forced expiratory volume in the first
second (FEV1); in the CAMP study, more than 1,000 chil-
dren with mild to moderate asthma were enrolled andfollowed to adulthood in the US and in Toronto, Canada
[46]. Similarly, a prospective birth cohort study of more
than 1,000 children from New Zealand found no effect of
BMI on AHR [23]. Other studies suggested increased AHR
to methacholine and worse exercise-induced broncho-
spasm in obese versus non-obese children and adoles-
cents [47-50].
Inflammation
Adipose tissue is involved in the production and release
of hormones as well as cytokines, which may both con-
tribute to obesity-related insulin resistance, cardiovascu-
lar morbidities, hypertension, and metabolic disorders,
as well as asthma [51,52]. Obesity is associated with in-
creased adipocyte-driven pro-inflammatory activity result-
ing in chronic local and systemic inflammation [53,54].
One of the adipokines released by adipocytes is leptin, and
serum leptin concentrations are increased in obesity. In
children, increased serum leptin is associated with severity
of exercise-induced bronchoconstriction [50], low-peak ex-
piratory flow rate [55], and higher asthma prevalence in
prepubertal boys [56], as well as peri- and postpubertal
girls [57]. In contrast, adiponectin, which is also secreted
from adipose tissue, is thought to inhibit the production
and effects of pro-inflammatory cytokines such as tumor
necrosis factor-α and interleukin (IL)-6 and induces the ex-
pression of the anti-inflammatory cytokines IL-1 receptor
antagonist and IL-10 [52]. Serum adiponectin levels have
been reported to be associated with asthma severity [33],
and adverse clinical outcomes of asthma [58], as well as
exercise-induced bronchoconstriction in children [50,52].
Adipokines may change the T helper cell balance in favor
of a T helper cell type 1 (Th1) response, as it is seen in
asthma associated with obesity [59,60]. Inflammation in al-
lergic disease is usually dominated by Th2. However, airway
disease in obese asthmatics is not typically characterized by
eosinophilic/TH2 inflammation. In fact, obese children
with asthma were found to have significantly higher Th1
and lower Th2 responses to specific stimuli compared with
non-obese asthmatic children [61]. In support of this, stud-
ies in asthmatics have shown that increased BMI was in-
versely related to sputum eosinophils and FeNO [25,62,63].
Interestingly, neutrophil-predominant airway inflammation
has also been described in obese women with asthma
[64,65], and weight loss by exercise or dietary changes re-
sults in a decrease in airway neutrophils [66].
Nitric oxide and ADMA
Asymmetric dimethylarginine (ADMA), a product of pro-
tein degradation, acts as competitive nitric oxide synthase
(NOS) inhibitor and as such is involved in the pathogenesis
of cardiovascular disease, diabetes, and asthma [67-70].
ADMA levels were increased in mouse lungs from a model
of allergic airway inflammation [69] and also increased
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eosinophilic asthma following a controlled inhaled allergen
challenge [69]. In pediatric asthma, ADMA was found
to be increased in exhaled breath condensate [71] and in
sputum [69]. Sputum ADMA and decreased L-arginine:
ADMA ratio, which can be used as a marker of NOS im-
pairment, correlated with reduced FeNO [69]. The previ-
ously mentioned inverse association between BMI and
FeNO in asthma [62,63] may therefore be explained by an
imbalance between NOS substrate L-arginine and its in-
hibitor, ADMA.
Interestingly, in a cross-sectional study of participants
from the Severe Asthma Research Program (SARP), sub-
jects with late-onset asthma (>12 years) had higher
ADMA and lower L-arginine plasma levels compared to
subjects with early-onset asthma [72]. The L-arginine:
ADMA ratio in plasma was inversely correlated with BMI
in late-onset, but not early-onset asthma, suggestive of
NOS impairment in obese late-onset asthma. In addition,
a reduced L-arginine:ADMA ratio in late-onset asthma
was also associated with less serum IgE, increased respira-
tory symptoms, lower lung volumes, and worse asthma
quality of life [72]. These studies demonstrated that
clinical-biological phenotyping may help unravel relevant
pathways in asthma beyond inflammation [73].
Nutrition and developmental programming
Certain nutrients, such as antioxidants and saturated
fatty acids may represent a link between obesity and
asthma [14], as they play an important role in oxidative
lung damage and decreased lung defense against envir-
onmental hazards [41]. There is also increasing evidence
that nutrition in infancy and even in utero has a major
influence on later predisposition to cardiovascular, meta-
bolic, and allergic diseases [74,75]. As recently reviewed
elsewhere [41], abnormalities in the lipid and/or glucose
metabolism early in life have the potential to contribute
to the pathogenesis of lung disease and asthma later in
life [41]. A healthy diet in pregnancy is important for
lung development and innervation in the offspring, and
imbalances can lead to airway hyperreactivity independ-
ent of the postnatal diet. In addition, the development of
innate and adaptive immunity may also be affected by
poor prenatal diet, which may result in increased suscep-
tibility to infections with respiratory viruses such as re-
spiratory syncytial virus and human rhinovirus, which
both predispose to recurrent wheezing and asthma in
childhood [41,76,77]. Metabolic and immune program-
ming are also under epigenetic regulation, and there is
increasing evidence now that nutrition can influence
long-term health outcomes by modulation of epigenetic
programming [78]. Interestingly, experimental studies
have shown that immune programming can be modu-
lated by the gut microbiome and that manipulation ofthe microbiome can prevent not only allergic disease
[79,80] but also the risk of obesity, cardiovascular, and
metabolic disease [81].
Conclusions
In summary, the link between obesity and diabetes with
asthma is complex. Metabolic disorders may affect the
lungs in many ways, which includes changes in the me-
chanics of breathing, by causing or contributing to inflam-
mation and abnormalities in the L-arginine metabolism
and by modifying the metabolic and immune program-
ming. Modification of the epigenetic programming through
intrauterine exposures to environmental triggers including
altered lipid and/or glucose metabolism of the mother may
contribute to the observed increase in incident pediatric
asthma. Supportive interventions in the treatment of
obese/overweight asthmatics should include weight loss.
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